Navigation Links
Duke awarded up to $43 million to develop test for dirty bomb/radiation exposure

DURHAM, N.C. Duke University has received a $3.7 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop a rapid and accurate genomic-based diagnostic test that can determine if a person has been exposed to radiation from a dirty bomb or nuclear attack. In the event that all option years are exercised by the government, Duke University could receive up to $43.6 million from the contract.

"Since 9/11, there has been national concern about the possibility of a terrorist attack in the U.S. involving radiological or nuclear materials. Such an attack could kill or injure hundreds of thousands of people," says John Chute, M.D., associate professor of medicine at Duke and principal investigator of the project. "The problem is that right now, we don't have any way to rapidly screen thousands of people to determine their level of radiation exposure. Many people who suffer radiation injury can recover and survive if they are promptly and properly treated."

BARDA is part of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services. It manages Project BioShield and the Public Health Emergency Medical Countermeasures Enterprise, two organizations charged with the development of medical response to pandemic disease and countermeasures for chemical, biological and nuclear attacks.

The award builds upon Chute's previous collaborations at Duke with Joseph Nevins, Ph.D. and Nelson Chao, M.D. that identified a set of 25 genes in human peripheral blood that are activated in response to radiation. Chute says that radiation exposure causes a characteristic pattern of expression in those 25 genes and this "signature" can diagnose radiation status with over 90 percent accuracy. Chute's earlier work was supported by a $25 million grant from the National Institutes of Allergy and Infectious Diseases that established the Duke Center for Medical Countermeasures Against Radiation, now in its fifth year of funding.

The new contract calls for Chute and his team at Duke to further validate the accuracy of the gene profile in animal and human testing. Collaborators at DxTerity Diagnostics, a biotechnology company based in California, will utilize the Duke gene panel to develop a rapid gene expression test while colleagues at the University of Arizona and Invetech Corporation will design and develop the instrument in which the assay will be performed. The end product will be a portable, 30-minute test for radiation injury that can be used to triage thousands of individuals in a short time following a radiological or nuclear attack.

"The Homeland Security Council document, 'Planning Guidance for Response to a Nuclear Detonation' indicates that a 10-kiloton improvised nuclear device would likely be lethal to individuals within about a half-mile radius of the blast," says Chute. "Outside this zone, however, thousands of individuals would be exposed to high-dose radiation but may be able to survive with prompt medical intervention. Further from the blast area, there would be additional thousands who have suffered little or no exposure, and may not need medical attention, but who will still be seeking it."

Chute says that such a scenario will require early and accurate triage of mass casualties to provide an effective health care response. "Imagine a blast zone with a ring of triage stations at the perimeter. We believe that using our diagnostic assay in such points would allow us to screen tens of thousands of individuals in a 24-hour period and to distinguish true radiation victims from the uninjured," says Chute.

Chute says the assay will involve a single collection of only a few drops of blood that will be analyzed in a fully automated instrument with each result provided in about 30 minutes. That dramatically shortens the time it currently takes to analyze large numbers of genes, a process that takes several days and requires large equipment. Researchers hope to have a prototype ready for demonstration by 2012.


Contact: Michelle Gailiun
Duke University Medical Center

Related biology news :

1. Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant awarded to Johns Hopkins Early Career investigator
2. Cylex(TM) Awarded New CPT Code For Its ImmuKnow(R) Assay
3. LSUHSC awarded multi-million dollar grant to reduce pneumonia
4. K-State plant pathology professor awarded international professorship for Latin America
5. Penn, Georgia collaboration awarded $14.6 million to expand pathogen database
6. Air Force Center of Excellence awarded in nanostructures and improved cognition
7. Stanford researchers awarded $6.27 million to study energy efficiency and human behavior
8. University of Miami facility awarded prestigious LEED Green Building Certification
9. Professor Suzanne Cory awarded 2009 Pearl Meister Greengard Prize
10. UNC awarded $6.2 million renewal grant by NIH Rare Diseases Research Network
11. VBI awarded $27 million from NIH to support infectious disease research
Post Your Comments:
(Date:11/26/2015)... Research and Markets ( ) has announced the ... and Patent Infringement Risk Analysis" report to their ... Fingerprint sensors using capacitive technology represent a fast ... Idex forecasts an increase of 360% of the number ... the fingerprint sensor market between 2014 and 2017 (source ...
(Date:11/20/2015)... , November 20, 2015 NXTD ... focused on the growing mobile commerce market and creator ... Gino Pereira , was recently interviewed on The ... air on this weekend on Bloomberg Europe , ... . --> NXTD ) ("NXT-ID" or the ...
(Date:11/19/2015)... , Nov. 19, 2015  Based on its in-depth ... Sullivan recognizes BIO-key with the 2015 Global Frost & ... Frost & Sullivan presents this award to the company ... to the needs of the market it serves. The ... meets and expands on customer base demands, the overall ...
Breaking Biology News(10 mins):
(Date:11/28/2015)... Seoul, South Korea (PRWEB) , ... November 28, 2015 , ... ... new class of eco-friendly avian, porcine and rodent control solutions , ... such as peppermint and cinnamon oil, works across all sensory modalities including visual, smell, ...
(Date:11/27/2015)... CHESTERFIELD, United Kingdom , Nov. 27, 2015 /PRNewswire/--  ... specialty biopharmaceutical company, announced today that it has closed ... systems (CMDS) business to Guerbet (GBT- NYSE Euronext) in ... CMDS operations encompassed four manufacturing facilities and a total ... nearly 75 in the St. Louis ...
(Date:11/27/2015)... ... 27, 2015 , ... Pittcon is pleased to announce the ... in symposia, oral sessions, workshops, awards, and posters. The core of the ... such as, but not limited to, biotechnology, biomedical, drug discovery, environmental, food science, ...
(Date:11/27/2015)... 2015 --> ... companion diagnostics is one of the major ... pharmaceutical companies and diagnostic manufacturers working together ... . --> ... global cancer biomarkers market spread across 89 ...
Breaking Biology Technology: